Clinical Trial Update: Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of temsirolimus and cixutumumab in locally advanced, metastatic, or recurrent soft tissue sarcoma and osteosarcoma; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Cixutumumab (Cixutumumab)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Osteosarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2015-07-30